BR0203747A - Molecules with antitumor activity and process for obtaining them - Google Patents

Molecules with antitumor activity and process for obtaining them

Info

Publication number
BR0203747A
BR0203747A BR0203747-5A BR0203747A BR0203747A BR 0203747 A BR0203747 A BR 0203747A BR 0203747 A BR0203747 A BR 0203747A BR 0203747 A BR0203747 A BR 0203747A
Authority
BR
Brazil
Prior art keywords
molecules
obtaining
antitumor activity
acridine
antitumor
Prior art date
Application number
BR0203747-5A
Other languages
Portuguese (pt)
Inventor
Ivan Da Rocha Pitta
Maria Do Carmo Alves De Lima
Suely Lins Galdino
Jacques Honor Augustin Barbe
Original Assignee
Conselho Nacional Cnpq
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conselho Nacional Cnpq filed Critical Conselho Nacional Cnpq
Priority to BR0203747-5A priority Critical patent/BR0203747A/en
Priority to PCT/BR2003/000128 priority patent/WO2004024058A2/en
Publication of BR0203747A publication Critical patent/BR0203747A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Abstract

"MOLéCULAS COM ATIVIDADE ANTITUMORAL E PROCESSO PARA SUA OBTENçãO". Síntese e identificação estrutural de novos compostos acridino-tiazolidínicos e acridino-imidaziolidínicos com atividade antitumoral e seu uso terapêutico como drogas antitumorais."Molecules with anti-tumor activity and process for obtaining them". Synthesis and structural identification of novel acridine thiazolidine and acridine imidaziolidine compounds with antitumor activity and their therapeutic use as antitumor drugs.

BR0203747-5A 2002-09-10 2002-09-10 Molecules with antitumor activity and process for obtaining them BR0203747A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR0203747-5A BR0203747A (en) 2002-09-10 2002-09-10 Molecules with antitumor activity and process for obtaining them
PCT/BR2003/000128 WO2004024058A2 (en) 2002-09-10 2003-09-09 Molecules with antitumor activity and chemical synthesis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0203747-5A BR0203747A (en) 2002-09-10 2002-09-10 Molecules with antitumor activity and process for obtaining them

Publications (1)

Publication Number Publication Date
BR0203747A true BR0203747A (en) 2004-05-25

Family

ID=31983570

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0203747-5A BR0203747A (en) 2002-09-10 2002-09-10 Molecules with antitumor activity and process for obtaining them

Country Status (2)

Country Link
BR (1) BR0203747A (en)
WO (1) WO2004024058A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20042475A1 (en) * 2004-12-23 2005-03-23 Cell Therapeutics Europe Srl USE OF THIAZOLIDINONIC DERIVATIVES AS THERAPEUTIC AGENTS
WO2007059195A1 (en) * 2005-11-14 2007-05-24 University Of Southern California Integrin-binding small molecules
BRPI0601827A (en) * 2006-03-24 2007-11-27 Univ Fed Pernambuco molecules with antitumor activity
BRPI1101273B1 (en) * 2011-03-10 2022-07-19 Universidade Federal De Pernambuco IMIDAZOLIDINE AND THIAZOLDINE MOLECULES WITH ANTI-T.CRUZI ACTIVITIES
WO2013053034A2 (en) * 2011-10-10 2013-04-18 Universidade Federal De Pernambuco - Ufpe Thiazacridines used in anti-cancer therapy
CN107954938A (en) * 2017-12-01 2018-04-24 苏州艾缇克药物化学有限公司 A kind of synthetic method of 1H- imidazoles -4- formic acid

Also Published As

Publication number Publication date
WO2004024058A3 (en) 2004-05-27
WO2004024058A2 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
BRPI0415613A (en) novel diazaspiroalkane compounds and their use in the treatment of ccr8-mediated diseases
DE69943266D1 (en) DRUGS FOR THE TREATMENT OF HIV-INFECTED MAMMALS
HUP0000944A2 (en) Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene and processes for preparing said compound
BR0309242A (en) Acyl-4-carboxyphenyl urea derivatives, process for their preparation and application
BR0114635A (en) Anticholinergics applicable as a medicine as well as a process for their preparation
GT199900054A (en) USE OF DIHYDROPYRIMIDINES AS MEDICATION AND NEW SUBSTANCES. ACE.
DE69735851D1 (en) METHOD FOR ACTIVATING HUMAN, ANTIGEN-ACTIVATING CELLS, ACTIVATED HUMAN, ANTIGEN-ACTIVATING CELLS, AND APPLICATIONS THEREOF
TR200100918T2 (en) Inhibition of RAF kinase using aryl and heteroaryl substituted ureas
BRPI0315296B8 (en) spirocyclic cyclohexanol derivatives, medicine including at least one spirocyclic cyclohexane derivative and use of a spirocyclic cyclohexane derivative
BR0317139A (en) Methods and compounds for the production of dipeptidyl peptidase iv inhibitors and their intermediates
UY27417A1 (en) AROMATIC BICYCLIC COMPOUNDS REPLACED WITH AMINO-RENT, PROCEDURE FOR PREPARATION AND USE AS A MEDICINAL PRODUCT
BRPI0411582A (en) hydrolytically resistant boron-containing therapeutic substances and method of use
BR0013727A (en) Sulfonylcarboxamide derivatives, process for their preparation and use as a medicine
BR0215622A (en) Glutaminyl-based dpiv inhibitors
BR9712816A (en) Benzamidine derivatives and their use as drugs with an ltb4 antagonistic activity
ATE240744T1 (en) USE OF CSF-1 INHIBITORS
GEP20022653B (en) Processes and Intermediates for Preparing Anti-Cancer Compounds
BRPI0512974A (en) New Hydantoin Derivatives for the Treatment of Obstructive Airway Diseases
BR0203747A (en) Molecules with antitumor activity and process for obtaining them
PT1015421E (en) NEW PHENYLAMIDINE DERIVATIVES PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
ITMI20020773A0 (en) DRUGS FOR THE TREATMENT OF ARTHRITIS
EA200700115A1 (en) MEDICINE
ATE368649T1 (en) CYANOGUANIDINE PRODRUGS
DE60229867D1 (en) TARGETED LIGANDS AGAINST PEYER'S FLAKE AND / OR M CELLS
BR0008681A (en) Derivatives of 3-amino -3-arylpropan-1-ol, process for obtaining it, medicine and its use

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: UNIVERSIDADE FEDERAL DE PERNAMBUCO - UFPE (BR/PE)

Free format text: TRANSFERIDO DE: CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTIFICO E TECNOLOGICO - CNPQ

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08E Application fees: payment of additional fee required [chapter 8.5 patent gazette]

Free format text: COMPLEMENTAR A RETRIBUICAO DA(S) 13A. ANUIDADE(S), DE ACORDO COM TABELA VIGENTE, REFERENTE A(S) GUIA(S) DE RECOLHIMENTO 22140902842-3.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08G Application fees: restoration [chapter 8.7 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]